Mitral valve prolapse (MVP) is a condition in which the flaps (cusps) of the heart’s mitral valve do not close evenly or smoothly. Normally, the mitral valve closes snugly to prevent blood from flowing backward into the heart’s upper chamber (left atrium) when the lower chamber (left ventricle) contracts. When one or both of the valve’s flaps bulge or prolapse back into the left atrium during the heart’s contraction, it is considered a mitral valve prolapse.
There are several potential causes of mitral valve prolapse (MVP):
It’s important to note that while these factors may increase the risk of developing MVP, not everyone with these risk factors will develop the condition.
Mitral valve prolapse (MVP) often presents with symptoms such as irregular or rapid heartbeats (palpitations), occasional sharp chest pains, persistent fatigue, difficulty breathing during physical activity or while lying flat, sensations of dizziness or lightheadedness, heightened anxiety or panic attacks, and sometimes migraine headaches. These symptoms can vary in severity and frequency from person to person.
Mitral valve prolapse (MVP) risk factors include family history, connective tissue disorders, age (especially women aged 20–40), heart structural issues, and high blood pressure or past heart problems.
Mitral valve prolapse (MVP) is typically diagnosed through:
These diagnostic tests help healthcare professionals confirm the presence of MVP and assess its severity.
Possible treatments for mitral valve prolapse (MVP) include lifestyle changes, medications to manage symptoms, surgical intervention for severe cases, antibiotics to prevent infections, and regular monitoring through check-ups and echocardiograms. Treatment plans are personalized based on symptom severity and individual health factors.
There are no specific steps to prevent mitral valve prolapse since it’s often congenital or related to genetic factors. Maintaining a healthy lifestyle, managing stress, attending regular medical check-ups, and following treatment recommendations can potentially reduce the risk of complications from MVP.
Untreated mitral valve prolapse (MVP) can lead to complications such as mitral valve regurgitation, infective endocarditis, arrhythmias, heart failure, and stroke.